A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
Abroad (travel likely)RecruitingPHASE1
Conditions
Leiomyosarcoma · Soft-tissue Sarcomas
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Elise Nassif, MD)
Study leads
Elise Nassif, MD
Principal Investigator
M.D. Anderson Cancer Center